A majority of fragile X males with methylated, full mutation alleles have significant levels of FMR1 messenger RNA

Research output: Contribution to journalArticle

57 Scopus citations

Abstract

FMR1 mRNA levels were determined in peripheral blood leucocytes for 48 fragile X males with methylated, full mutation alleles that are resistant to cleavage by methylation sensitive enzymes. Using quantitative (fluorescence) RT-PCR, we observed that more than half of these males produce FMR1 mRNA, with some mRNA levels approaching those found in normal subjects. In none of the samples analysed was there any evidence of premutation alleles. These results suggest that the assumed relationship between enzyme resistance and FMR1 gene silencing may not be generally valid. Despite the presence of FMR1 mRNA in some subjects, no FMRP production was detected by either immunocytochemistry or western blotting. The low/absent FMRP levels are probably a reflection of a post-transcriptional effect such as a defect in translation.

Original languageEnglish (US)
Pages (from-to)453-456
Number of pages4
JournalJournal of Medical Genetics
Volume38
Issue number7
StatePublished - 2001

Keywords

  • Gene silencing
  • Neurodevelopment
  • Quantitative RT-PCR
  • Trinucleotide repeat

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)

Fingerprint Dive into the research topics of 'A majority of fragile X males with methylated, full mutation alleles have significant levels of FMR1 messenger RNA'. Together they form a unique fingerprint.

  • Cite this